Schizophrenia - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 309 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Schizophrenia - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H1 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorganized speech and disorganized behavior. Risk factors inc

Read More
  • List of Figures
  • Number of Products under Development for Schizophrenia, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 2017
  • Nu
Read More
  • List of Tables
  • Number of Products under Development for Schizophrenia, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
  • Number of Products under Development by Univer
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 6
  • Schizophrenia - Overview 7
  • Schizophrenia - Therapeutics Development 8
  • Schizophrenia - Therapeutics Assessment 24
  • Schizophrenia - Companies Involved in Therapeutics Development 36
  • Schizophrenia - Drug Profiles 73
  • Schizophrenia - Dormant Projects 274
  • Schizophrenia - Discontinued Products 282
  • Schizophrenia - Product Development Milestones 285
  • Appendix 295
Read More

Please select a license type

Share

Related Products

Global Markets DirectSchizophrenia - Pipeline Review, H1 2017Product ThumbnailSchizophrenia - Pipeline Review, H1 2017, Industry ReportProduct #: 797262
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved